Investors & News / Media Coverage / Media Coverage Year None20222020201920172016 Mar 08, 2019 FutureTech Podcast featuring Douglas W. Losordo, MD, FACC, FAHA, Executive Vice President, Global Head of Research and Development, Caladrius Biosciences – Cells, Tissue, and Repair Aug 08, 2017 Cell Therapy Trial Targets Type 1 Diabetes In Children Jul 20, 2017 Type 1 Diabetes Cell Therapy Study Shows Promise in Pediatrics Apr 13, 2017 Practical Cure Project Update: Caladrius Biosciences Inc. Treg Apr 07, 2017 Close Concerns Highlights Caladrius Type 1 Diabetes Program and Recent CIRM Grant Nov 14, 2016 CEOCFO Magazine Interview with Dr. David Mazzo Oct 19, 2016 Stock News Now Interview with Dr. David Mazzo Sep 14, 2016 A first for Fast Track designation Sep 05, 2016 FDA Provides First Known Fast Track Designation for Type 1 Diabetes First page « first Previous page ‹ previous Page 1 Current page 2 Print Page RSS Feeds Email Alerts
Year None20222020201920172016 Mar 08, 2019 FutureTech Podcast featuring Douglas W. Losordo, MD, FACC, FAHA, Executive Vice President, Global Head of Research and Development, Caladrius Biosciences – Cells, Tissue, and Repair Aug 08, 2017 Cell Therapy Trial Targets Type 1 Diabetes In Children Jul 20, 2017 Type 1 Diabetes Cell Therapy Study Shows Promise in Pediatrics Apr 13, 2017 Practical Cure Project Update: Caladrius Biosciences Inc. Treg Apr 07, 2017 Close Concerns Highlights Caladrius Type 1 Diabetes Program and Recent CIRM Grant Nov 14, 2016 CEOCFO Magazine Interview with Dr. David Mazzo Oct 19, 2016 Stock News Now Interview with Dr. David Mazzo Sep 14, 2016 A first for Fast Track designation Sep 05, 2016 FDA Provides First Known Fast Track Designation for Type 1 Diabetes First page « first Previous page ‹ previous Page 1 Current page 2
Mar 08, 2019 FutureTech Podcast featuring Douglas W. Losordo, MD, FACC, FAHA, Executive Vice President, Global Head of Research and Development, Caladrius Biosciences – Cells, Tissue, and Repair